[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352177-105":59,"doc-detail-352177-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","disruption-of-emt-signaling-and-migration-by-moringaoleifera-leaf-powder-silver-nanoparticles-molp-agnps-in-hela-cervical-cancer-cells","Disruption of EMT Signaling and Migration by Moringaoleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells","","Objective: Evaluate the anticancer potential of Moringa oleifera leaf powder–silver nanoparticles (MOLP-AgNPs) by measuring epithelial–mesenchymal transition (EMT) markers and cell migration in HeLa cervical cancer cells. Methods: HeLa cells received MOLP-AgNPs at 2, 4, and 6 µg/mL, with an untreated control; viability was assessed by trypan blue exclusion, migration by scratch assay, and EMT proteins Snail and vimentin by immunofluorescence. Result: Migration decreased dose-dependently (p \u003C 0.05), with Snail and vimentin downregulated (p \u003C 0.001). Conclusion: MOLP-AgNPs inhibit EMT-driven migration, supporting further study in metastatic models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/disruption-of-emt-signaling-and-migration-by-moringaoleifera-leaf-powder-silver-nanoparticles-molp-agnps-in-hela-cervical-cancer-cells/352177/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/disruption-of-emt-signaling-and-migration-by-moringaoleifera-leaf-powder-silver-nanoparticles-molp-agnps-in-hela-cervical-cancer-cells/352177.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of the study on MOLP-AgNPs?","Question",{"text":112,"@type":113},"To assess whether MOLP-AgNPs exert anticancer effects by impacting EMT markers and inhibiting migration in HeLa cervical cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were MOLP-AgNPs tested in HeLa cells?",{"text":117,"@type":113},"HeLa cells were treated with MOLP-AgNPs at 2, 4, and 6 µg/mL, compared with an untreated control group, and cell viability was checked using trypan blue exclusion.",{"name":119,"@type":110,"acceptedAnswer":120},"What results indicate that EMT is suppressed after treatment?",{"text":121,"@type":113},"MOLP-AgNPs significantly inhibited migration in a dose-dependent manner, and immunofluorescence showed marked downregulation of Snail and vimentin expression, consistent with suppression of EMT-related pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352177,1790185880,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:07/18/2025 Acceptance:02/24/2026 Published:03/05/2026 |\n| --- | --- |\n\nDisruption of EMT Signaling and Migration by Moringaoleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells  \nRaishaAnis Fatiha1, Christian Kencana Ngabdi1, Jihan Salwa Azizah1, Bintang Sukma Natalsah Putri2, Bayu Lestari3, Nik Ahmad Nizam Nik Malek4,5, Hendra Susanto6, Wibi Riawan7, Happy Kurnia Permatasari7 *  \nAbstract  \nObjective: This study aimed to evaluate the potential anticancer effect of Moringa oleifera leaf powder–silver nanoparticles (MOLP-AgNPs) by assessing their impact on epithelial–mesenchymal transition (EMT) markers and cell migration in HeLa cervical cancer cells. Methods: HeLa cells were treated with MOLP-AgNPs at concentrations of 2, 4, and 6 µg/mL, alongside an untreated control group. Cell viability was assessed using the trypan blue exclusion method to determine non-toxic concentrations. A scratch (wound-healing) assay was used to evaluate cell migration, while immunofluorescence staining was performed to detect the expression of EMT-related proteins Snail and vimentin. Result: MOLP-AgNPs significantly inhibited cell migration in a dose-dependent manner (p \u003C 0.05). Additionally, the expression of Snail and vimentin was markedly downregulated following treatment, indicating suppression of EMTrelated pathways (p \u003C 0.001). Conclusion: These exploratory preclinical findings suggest that MOLP-AgNPs exert antimigratory effects on cervical cancer cells by modulating EMT. Although HeLa is a non-metastatic cell line, this study highlights the potential of MOLP-AgNPs as a promising candidate for further investigation in metastatic cancer models.  \nKeywords: Cervical cancer-HeLa-Moringa oleifera-Snail-Vimentin  \nAsian Pac J Cancer Prev, 27 (3), 981-988  \nIntroduction  \nCervical cancer is a malignant disease initiated by dysplastic changes in the cervical epithelium, wherein abnormal cells undergo unregulated proliferation and evade apoptosis. The majority of cervical cancer cases are histologically classified as squamous cell carcinoma, accounting for approximately 90% of all diagnoses [1] . Globally, cervical cancer remains one of the leading malignancies affecting women. According to the World Health Organization (WHO), it ranks as the fourth most common cancer in women, with an estimated 660,000 new cases and 350,000 deaths reported in 2022. Notably, about 94% of these deaths occurred in low-and middle-income countries, where access to HPV vaccination, routine screening, and healthcare services remains limited [2, 3] . Persistent infection with high-risk Human  \nPapillomavirus (HPV), particularly genotypes 16, 18, 31, and 33, represents the principal etiological factor for cervical cancer. Transmission is frequently associated with high-risk sexual behaviors, including early sexual debut and multiple sexual partners. HPV is capable of infecting mucosal epithelial cells in the oral, anogenital, and esophageal regions, where it may induce precancerous lesions over time. Additional risk factors include high parity, immunosuppression, and poor access to health services [4, 5]. Oncogenes E6 and E7 play pivotal roles in HPV-mediated carcinogenesis by dysregulating cell cycle control. These proteins interfere with tumor suppressor functions and facilitate immune evasion through mechanisms such as suppression ofTLR9 expression and disruption of NF-κB signaling, ultimately enabling viral persistence and malignant transformation [6] .  \nDuring HPV persistence and progression to cervical  \n1Biomedical Science Master’s Program, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia. 2Medical Program, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia. 3Pharmacology Department, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia. 4Department of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, Skudai 81310, Mala","cbCaikEqSp99JzMw","https://ap.wps.com/l/cbCaikEqSp99JzMw","pdf",894878,"English","# Abstract\n# Introduction\n## EMT and migration background\n## HPV and molecular drivers\n# Materials and Methods\n## Cell treatment and viability assessment\n## Migration assessment\n## EMT protein detection","[{\"question\":\"What was the objective of the study on MOLP-AgNPs?\",\"answer\":\"To assess whether MOLP-AgNPs exert anticancer effects by impacting EMT markers and inhibiting migration in HeLa cervical cancer cells.\"},{\"question\":\"How were MOLP-AgNPs tested in HeLa cells?\",\"answer\":\"HeLa cells were treated with MOLP-AgNPs at 2, 4, and 6 µg/mL, compared with an untreated control group, and cell viability was checked using trypan blue exclusion.\"},{\"question\":\"What results indicate that EMT is suppressed after treatment?\",\"answer\":\"MOLP-AgNPs significantly inhibited migration in a dose-dependent manner, and immunofluorescence showed marked downregulation of Snail and vimentin expression, consistent with suppression of EMT-related pathways.\"}]","Disruption of EMT Signaling and Migration by Moringaoleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells | PDF",1790098148,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/936be25750d8e6c688e071744d02deb4.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d707b7666a6aecca95bbd2fe4849b343.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8127122976b8900e1177398efc2ad90b.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b573ad5921e63f89358fbba80ff736b7.webp",980,1385]